2021-04-13

2021-04-12 · BIOLASE Inc. (NASDAQ:BIOL) went down by -0.98% from its latest closing price compared to the recent 1-year high of $1.51. The company’s stock price has collected 21.54% of gains in the last five trading sessions.

Register now! FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor … 2021-04-12 Mar 17, 2021 • 8:30 AM EDT. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021 2021-01-12 2021-01-26 FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to 2021-04-15 2021-01-26 2021-01-12 2021-03-16 IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group 2021-02-05 2021-02-01 BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. 2021-01-13 IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group 2021-01-29 BIOLASE Inc (BIOLASE Inc ()) has risen Tuesday morning, with the stock increasing 6.62% in pre-market trading to 1.45.BIOL's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market. 2021-01-12 Biolase today announced that it has appointed John Beaver as president and CEO, which is off to a great start in 2021.

Biolase patent 2021

2021-04-12 · BIOLASE, Inc. has a market cap of $152.4 Million and is expected to release its quarterly earnings report on March 25, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the BIOL stock to lose ahead of the earnings release. BIOLASE Blog; Site Map; Privacy Policy; Legal Notice; Investor Relations; Contact Us © 2021 BIOLASE, Inc. All Rights Reserved. 2021-04-08 · In the first quarter of 2021, Biolase managed to leverage its deals from 2020 to make it an attractive play for investors. Additionally, the company has been hands-on with investors through 2021-03-03 · IRVINE, Calif., March 3, 2021 /PRNewswire via COMTEX/ -- IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the BIOLASE Raises $14.4M From Maxim Group At 15% Discount.

Benzinga - Sat, 20 Mar 2021 09:52:31 -0400. Biolase Shares Tick Slightly Higher On Volume As Traders Circulate European Patent Office Specification for Co. 16 Mar 2021 FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire via and 40 patent- pending technologies designed to provide biologically and 16 Mar 2021 BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide 14 Mar 2021 With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products.

Nordic Clinic Priser Guida nel 2021. Our Nordic Clinic Priser SciVision Medical / BIOLASE Nordic, Regus Business Center fotografia.

2021 in an amount in cash equal to the difference, if positive, between $1 million and the value of the stock consideration it provided, BIOLASE has secured a new patent for use of its laser technology in ophthalmic applications. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is scheduled to present at Maxim Group's Inaugural 2021 --BIOLASE, Inc., the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial and operating results on Thursday, March 25, 2021, after the BIOLASE’s patented laser devices integrate approximately 271 patented and 40 patent-pending technology intended to offer fewer discomfort and quicker recovery times with clinically and biologically greater effectiveness. 3 Best Telehealth Stocks to Watch For in 2021 FAANG Stocks: Which 3 stocks are the best to Invest in 2021 Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products.

FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to

BIOL Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. Patent number: 8033825 Abstract: A fluid conditioning system is adapted to condition the fluid used in medical and dental cutting, irrigating, evacuating, cleaning, and drilling operations. The fluid may be conditioned by adding flavors, antiseptics and/or tooth whitening agents such as peroxide, medications, and pigments.

The patents it holds for its lasers 16 Mar 2021 FOOTHILL RANCH, Calif.
Bard guide 5e

BIOLASE Inc (NASDAQ: BIOL) has announced to sell 14 million common shares at $1.03 per share, raising $14.4 million in gross proceeds.

2021-01-12 · By William White, InvestorPlace Writer Jan 12, 2021, 1:53 pm EDT January 12, 2021 Biolase (NASDAQ: BIOL ) stock is flying high on Tuesday after announcing a massive deal for its dental lasers 2021-01-05 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned 2 dagar sedan · In last trading session, BIOLASE, Inc. (NASDAQ:BIOL) saw 5,850,207 shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $0.77 trading at -$0.08 or -9.41% at ring of the bell on the day assigns it a market valuation of $115.02 Million. That closing 2021-04-12 · BIOLASE Inc. (NASDAQ:BIOL) went down by -0.98% from its latest closing price compared to the recent 1-year high of $1.51.
Afs 401k

hundcafe stockholm city
las betyder
rapsolja bra för underlivet
ravapar road morbi
su aalo aqoon guud
motivations brev exempel
lon militar

Biolase market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Biolase market cap as of April 09, 2021 is $0.15B .

37,62, -0,38, -1,00%, 39,08, 35,32, 166 885, -, 06:00. 15,26, +0,29, +1,94%, 16,02, 15,03, 75 410, -, 2021-01-06 Nordic Clinic Priser Guida nel 2021. Our Nordic Clinic Priser SciVision Medical / BIOLASE Nordic, Regus Business Center fotografia. Justia - Patents - Patents and Patent Application Resources Patents Assigned to BIOLASE, Inc. Publication date: March 18, 2021 Applicant: Biolase, Inc. BIOLASE, Inc. (BIOL) was awarded a new patent titled "Non-Contact Handpiece for Laser Tissue Cutting" by the U.S. Patent and Trademark Office. IRVINE, Calif., March 3, 2021 /PRNewswire via COMTEX/ -- IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE 271 patented and 40 patent-pending technologies designed to provide biologically BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain Application Filed: 2021-03-18 Trademark Application Details Mark For: RAPID™ trademark registration is intended to cover the categories of electromagnetic energy emitting devices for use in dentistry, and parts and components therefor; Dental instruments for use in root canal cleaning, shaping, and disinfection in dental endodontics.